| Check It! Positive Psychology Intervention to Improve Adherence in Adolescents With T1D (NCT02746627) | Vanderbilt University Medical Center | 2014-01-01 |
| Pilot Study Investigating the Feasibility of Determining the Endogenous Glucose Production During a Hypoglycaemia (NCT02028078) | Medical University of Graz | 2014-01-01 |
| Prematurity Prevalence Among T1D Patients and Its Characteristics Compared With Premature-born Non-diabetic Patients (NCT02929953) | Assaf Harofeh MC | 2014-01-01 |
| Effects of Vitamin C and E on Endothelial Function in Adolescent Diabetes (NCT02019186) | Nationwide Children's Hospital | 2013-12-01 |
| Post-exercise Appetite Responses in Type 1 Diabetes (NCT02208115) | Northumbria University | 2013-11-01 |
| Crossover Feasibility Study of Portable AP Device With Zone-MPC and HMS and Adapted I:C and Basal Insulin (NCT01929798) | Sansum Diabetes Research Institute | 2013-11-01 |
| A Study of the Safety and Efficacy of MK-1293 Compared to Lantus™ in Participants With Type 1 Diabetes Mellitus (T1DM) (MK-1293-003) (NCT02059161) | Merck Sharp & Dohme LLC | 2013-10-17 |
| Islet Cell Transplant for Type 1 Diabetes (NCT01909245) | City of Hope Medical Center | 2013-10-16 |
| A Study of Continuous Subcutaneous Insulin Infusion (CSII) Pump Function in Subjects With Type 1 Diabetes With Recombinant Human Hyaluronidase (rHuPH20) (NCT03662334) | Halozyme Therapeutics | 2013-10-03 |
| Mixed Meal Test in Type 1 Diabetes on Insulin Pump Therapy: Optimization of Artificial Pancreas (NCT02003274) | Azienda Ospedaliera Universitaria Integrata Verona | 2013-10-01 |
| Telecare in Type 1 Diabetes (T1D) Patients Treated by Insulin Pump (NCT01887431) | Assuta Hospital Systems | 2013-10-01 |
| Does Protein and Fat Content of Meal Increase Glucose Concentrations (NCT03333525) | TC Erciyes University | 2013-09-10 |
| Decision Coaching for Youth and Parents Considering Insulin Delivery Methods for Type 1 Diabetes (NCT04909580) | Margaret Lawson | 2013-09-05 |
| Closed Loop Control in Adolescents Using Heart Rate as Exercise Indicator (NCT01945060) | Marc Breton | 2013-09-01 |
| Protection Against Pneumococcal Infection in Children With T1DM (NCT01939522) | University of Oxford | 2013-08-01 |
| Incretin Axis in Type 1 Diabetes Mellitus (NCT02725502) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2013-07-01 |
| Lipid and Glycogen Metabolism in Patients With Impaired Glucose Tolerance and Calcium Sensing Receptor Mutations (NCT02023489) | Medical University of Vienna | 2013-07-01 |
| Telehealth Intervention for Youth With T1DM (NCT01782547) | Boston Children's Hospital | 2013-06-01 |
| Medtronic Minimed Overnight Closed-Loop System (NCT01881009) | Bruce A. Buckingham | 2013-06-01 |
| Artificial Pancreas Control System in an Outpatient Setting (NCT01871870) | Legacy Health System | 2013-05-01 |
| Pharmacologic Response and Safety of Inhaled Insulin in Type 1 Diabetes (NCT02713841) | Dance Biopharm Inc. | 2013-05-01 |
| Orchestra Pregnancy Observational Study in Poland (NCT01779141) | Medtronic MiniMed, Inc. | 2013-05-01 |
| Impact of ELKa, the Toolset for Food Exchanges Calculation on Metabolic Control in Pediatric Diabetic Patients. (NCT02194517) | Medical University of Warsaw | 2013-04-01 |
| Long Term Follow up of Recipients of Functional Islet Allografts (NCT01999374) | Rodolfo Alejandro | 2013-03-01 |
| Guidelines for Post-exercise Dietary Intake in T1DM (NCT01794650) | Northumbria University | 2013-03-01 |
| CONSISTENT 1: Metabolic and Safety Outcomes of Hylenex Recombinant (Hyaluronidase Human Injection) Preadministered at CSII Infusion Site in Participants With Type 1 Diabetes Mellitus (T1DM) (NCT01848990) | Halozyme Therapeutics | 2013-03-01 |
| Evaluation of a Simulation-Based Educational Tool for Personalized Feedback in Insulin Therapy Management (NCT01767831) | University of Virginia | 2013-03-01 |
| The Effects of RT-CGM on Glycemia and QoL in Patients With T1DM and IHA (NCT01787903) | Amsterdam UMC, location VUmc | 2013-02-01 |
| A Study of LY2605541 in Participants With Type 1 Diabetes Mellitus (NCT01792284) | Eli Lilly and Company | 2013-02-01 |
| Safety and Efficacy of Sotagliflozin (LX4211) in Patients With Inadequately Controlled Type 1 Diabetes Mellitus (NCT01742208) | Lexicon Pharmaceuticals | 2013-02-01 |
| A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A (NCT01724814) | Hanmi Pharmaceutical Company Limited | 2012-12-20 |
| The Effect of Uric Acid Lowering in Type 1 Diabetes (NCT02344602) | University Health Network, Toronto | 2012-12-18 |
| Closing the Loop in Adults With Type 1 Diabetes in the Home Setting (NCT01440140) | University of Cambridge | 2012-12-01 |
| Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus (NCT01621308) | Medical Research Foundation, The Netherlands | 2012-12-01 |
| Glucose-Dependent Insulinotropic Polypeptide - Effects on Markers of Bone Turnover in Patients With Type 1 Diabetes (NCT03195257) | Mikkel Christensen | 2012-11-17 |
| Detection of C-peptide in Youth With Longstanding Type 1 Diabetes Mellitus (NCT02131675) | Icahn School of Medicine at Mount Sinai | 2012-10-01 |
| Feasibility Study Using Zone-MPC Controller, HMS and Technosphere® Insulin Inhalation System From MannnKind Corp (NCT01874392) | Sansum Diabetes Research Institute | 2012-10-01 |
| Pet Ownership and Glucose Control in Type 1 Diabetes (NCT01733524) | University of Texas Southwestern Medical Center | 2012-10-01 |
| Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus (NCT01683266) | Sanofi | 2012-09-01 |
| Repeated Dose Study With a New Insulin Glargine Formulation and Lantus® on 24-hour Glucose Profile in Japanese Patients With Type 1 Diabetes Mellitus (NCT01676233) | Sanofi | 2012-09-01 |
| Comparison of a New Formulation of Insulin Glargine With Lantus® in Japanese Patients With Type 1 Diabetes Mellitus (NCT01689129) | Sanofi | 2012-09-01 |
| Development of an Advisory System for Glycemic Control During the Menstrual Cycle in Patient With Type 1 Diabetes (NCT01653210) | University of Virginia | 2012-08-01 |
| A Study Evaluating Safety and Efficacy of BIOD-123 Compared to Insulin Lispro (Humalog®) (NCT01686620) | Biodel | 2012-08-01 |
| Comparison of a New Formulation of Insulin Glargine With Lantus in Patients With Type 1 Diabetes Mellitus on Basal Plus Mealtime Insulin (NCT01658579) | Sanofi | 2012-08-01 |
| Type 1 Diabetes Mellitus Bone Mineral Density in Childhood and Adolescence (NCT01605149) | Creighton University | 2012-07-01 |
| Study Assessing an Insulin Pump-controlling Algorithm to Minimize Hypo and Hyper in Type 1 During CRC Setting (NCT01638299) | Animas Corporation | 2012-07-01 |
| Feasibility Study of Closed Loop Control in Type 1 Diabetes Using Heart Rate Monitoring as an Exercise Marker (NCT01582139) | University of Virginia | 2012-05-01 |
| Methylation of DNA in Children and Adolescents With Type 1 Diabetes Mellitus (METHYLDIAB) (NCT04139369) | Aristotle University Of Thessaloniki | 2012-05-01 |
| Tissue-Specific Metabolic Reprogramming in Diabetic Complications (NCT01823406) | University of Michigan | 2012-05-01 |
| Diabetes Adolescent and Family Group Therapy (NCT01626586) | Children's Hospital Medical Center, Cincinnati | 2012-05-01 |
| A Pilot Study of Moderate Hyperbilirubinemia in Type 1 Diabetes Mellitus (NCT01421355) | Brigham and Women's Hospital | 2012-05-01 |
| Outpatient Control-to-Range: System and Monitoring Testing (NCT01578980) | University of Virginia | 2012-04-01 |
| MSC Administration for the Management of Type 1 Diabetic Patients (NCT02893306) | Universidad del Desarrollo | 2012-03-01 |
| Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes (NCT01544881) | Mannkind Corporation | 2012-03-01 |
| Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Montpellier (NCT01447979) | University of Virginia | 2012-03-01 |
| Cardiopulmonary Fitness, Lung Function, Muscular Oxygen Saturation, and Quality of Life in T1DM (NCT01727661) | National Taiwan University Hospital | 2012-02-01 |
| DiaPort Closed-Loop Artificial Pancreas (NCT01555788) | University Hospital, Montpellier | 2012-02-01 |
| Lisofylline as Continuous Subcutaneous and Intravenous Administration in Subjects With Type 1 Diabetes Mellitus (NCT01603121) | Eastern Virginia Medical School | 2012-02-01 |
| BMS - Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of Dapagliflozin in Type 1 Diabetes (NCT01498185) | AstraZeneca | 2012-02-01 |
| Affect of RT-CGMS as Part of Clinical Care in Type 1 Diabetes Mellitus Patients (NCT01525784) | Assaf-Harofeh Medical Center | 2012-02-01 |
| Human Menstrual Blood-derived Mesenchymal Stem Cells Transplantation in Treating Type 1 Diabetic Patients (NCT01496339) | S-Evans Biosciences Co., Ltd. | 2012-01-01 |
| Lypo-hypertrofia Characterization in Diabetes (NCT02278926) | Niguarda Hospital | 2012-01-01 |
| Effect of a Medium Chain Triglyceride Supplemented Diet on Cognitive Function and Brain Activation in Type 1 Diabetes. (NCT01315171) | Yale University | 2012-01-01 |
| Effect of CSII and CGM on Progression of Late Diabetic Complications (NCT01454700) | Steen Andersen | 2011-12-01 |
| Effect of Acute Exercise on Endothelial Function in Patients With Type 1 Diabetes. (NCT01899872) | Hospital de Clinicas de Porto Alegre | 2011-12-01 |
| Single Dose Study With a New Insulin Glargine Formulation and Lantus® in Japanese Patients With Type 1 Diabetes Mellitus (NCT01493115) | Sanofi | 2011-11-01 |
| A Clinical Study of the Performance of a Glucose Blinding Protein-Based Continuous Glucose Monitor (GBP CGM) (NCT01469715) | University of Virginia | 2011-11-01 |
| Physiologic Response to Glucagon at Varying Insulin Levels (NCT01483651) | Legacy Health System | 2011-11-01 |
| Feasibility Study Using Zone-MPC Controller (Zone-Model Predictive Control) and Health Monitoring System (HMS) (NCT01472406) | Sansum Diabetes Research Institute | 2011-11-01 |
| A Performance Evaluation of the Enlite Glucose Sensor to Support a Full 144 Hours(6Days) of Use (NCT01464346) | Medtronic MiniMed, Inc. | 2011-11-01 |
| Pilot Study 1 of Outpatient Control-to-Range - System and Monitoring Testing (NCT01470807) | University of Virginia | 2011-10-01 |
| Feasibility Study of a Portable Artificial Pancreas System in Type 1 Diabetes Mellitus (T1DM) - Padova (NCT01447992) | University of Virginia | 2011-09-01 |
| Insulin Glulisine and Aspart in Postprandial Glycemic Control After High-GI Meal in Children With Type 1 Diabetes Mellitus (NCT01678235) | Medical University of Warsaw | 2011-09-01 |
| Clinical Trial Evaluating Technosphere® Insulin Versus Insulin Aspart in Subjects With Type 1 Diabetes Mellitus Over a 24-week Treatment Period (NCT01445951) | Mannkind Corporation | 2011-09-01 |
| Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age (NCT01421225) | Boston Children's Hospital | 2011-08-01 |
| Clinical Assessment of a Closed-loop Insulin Delivery System (NCT01534013) | Imperial College London | 2011-08-01 |
| Islet After Kidney Transplant for Type 1 Diabetes (NCT00784966) | Virginia Commonwealth University | 2011-08-01 |
| Best Timing of Insulin Bolus Before Meals of Different Contents (NCT01406496) | Kaplan Medical Center | 2011-08-01 |
| Ovarian Ageing in Type 1 Diabetes Mellitus (NCT01665716) | UMC Utrecht | 2011-07-01 |
| Constructed Intervention by Home and School Diabetes Nurse Visits on Diabetic Control of Children With Type I Diabetes (NCT01382459) | Soroka University Medical Center | 2011-07-01 |
| Feasibility Study Assessing The Ability Of An Insulin Pump-Controlling Algorithm To Minimize Hypoglycemia And Hyperglycemia In Patients With Type 1 Diabetes In A Clinical Research Setting (NCT01401751) | Animas Corporation | 2011-07-01 |
| Study of the Safety and Efficacy of Intravenous Alpha-1 Antitrypsin in Type 1 Diabetes Mellitus (NCT01304537) | Kamada, Ltd. | 2011-06-01 |
| IGF-I Induced Muscle Glucose Uptake and Interstitial IGF-I Concentrations (NCT01588093) | Peter Bang | 2011-04-01 |
| TAK-329 Glucose Clamp Study (NCT01311076) | Takeda | 2011-03-01 |
| Repeated Dosing Study With a New Insulin Glargine Formulation and Lantus® in Patients With Type 1 Diabetes Mellitus (NCT01349855) | Sanofi | 2011-03-01 |
| Rilonacept in Diabetes Mellitus Type 1: Safety Study (NCT00962026) | University of Texas Southwestern Medical Center | 2011-02-01 |
| Pramlintide Combined With Model Predictive Control Algorithm (NCT01434862) | University of Virginia | 2011-02-01 |
| A Study to Evaluate a Multiple Model Probabilistic Predictive Controller (MMPPC) for Closed Loop Insulin Delivery (NCT01492062) | Stanford University | 2011-02-01 |
| Safety and Efficacy of Arterial Delivery of Autologous Bone Marrow Cells in the Treatment of Insulin-Dependent Diabetes (NCT00971503) | University of Moron | 2011-02-01 |
| Efficacy and Safety of Insulin Glargine Versus. Neutral Protamine Hagedorn (NPH) Insulin in Children With Type 1 Diabetes Above 6 Years Old. (NCT01223131) | Sanofi | 2011-02-01 |
| Endothelial Dysfunction and Diabetes (NCT01097551) | Assistance Publique - Hôpitaux de Paris | 2011-01-01 |
| Bolus Calculator and Wireless Communication With Blood Glucose Meter in Management of Type 1 Diabetes Mellitus (T1DM). (NCT01677546) | Medical University of Warsaw | 2011-01-01 |
| Managing Insulin Pumps for Exercise - Study 1 (NCT01401127) | Buckinghamshire Healthcare NHS Trust | 2011-01-01 |
| Impact of c242T Polymorphism of p22phox in Diabetic type1 Nephropathy (NCT01371955) | University Hospital, Grenoble | 2011-01-01 |
| The Role of FTO Gene Polymorphism and Insulin Preparation in Obesity in Children With Type 1 Diabetes Mellitus (NCT01279161) | University of Bialystok | 2010-12-01 |
| T1DM Immunotherapy Using CD4+CD127lo/-CD25+ Polyclonal Tregs (NCT01210664) | University of California, San Francisco | 2010-11-01 |
| Real-time Adaptation to Changes in Insulin Sensitivity (NCT01261052) | Legacy Health System | 2010-11-01 |
| Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus (NCT01299012) | University at Buffalo | 2010-10-01 |
| Pulmonary Function Substudy for Subjects Enrolled in Studies MKC-TI-161, MKC-TI-162 or MKC-TI-166 (NCT01201928) | Mannkind Corporation | 2010-10-01 |
| Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Insulin (IN-105) in Type 1 Diabetes Patients (NCT01035801) | Biocon Limited | 2010-08-21 |